The National Alliance for Eye and Vision Research

NAEVR Logo

Vision Researchers Receive at Least $230M from ARRA/DOD Funding
NEI Awards 333 ARRA Grants. Click Here for More Information

NAEVR Announces Release of
The Silver Book®: Vision Loss
Volume II

NAEVR Supports World Glaucoma Week

NAEVR Participates in White House Conference on Aging

NAEVR CENTRAL AT ARVO ANNUAL MEETING

Contact Congress
Create a Video Message About Your Research
Meet With Department of Defense Representatives About Funding

Click Here to Learn More

House and Senate Appropriations Committees Approve Subcommittee Allocations

FASEB Estimates Impact of Sequestration on NIH Funding

NAEVR Announces Advocacy and Educational Opportunities at the 2012 ARVO Annual Meeting

NAEVR Requests FY2013 NEI Funding of $730 Million at House Public Witness Hearing and in Written Testimony Submitted to the Senate

NAEVR Releases Winter 2012 Contributor Report

NIH Director Dr. Collins Testifies Before the House on FY2013 Budget, NCATS Implementation

AEVR and Alliance for Aging Research Release The Silver Book®: Vision Loss Volume II

NAEVR Releases FY2013 Funding Requests to Congress: At Least $32 billion for NIH and $730 Million for NEI, $10 Million for Peer Reviewed Vision Trauma Research

U.S. Medicine Quotes NAEVR in Article about Vision Center of Excellence, Defense Vision Research Funding

VSOs Support Increased Funding For Vision Trauma Research in The Independent Budget and in Letter to Defense Appropriators

Director Dr. Collins Discusses the President’s Proposed FY2013 NIH Budget

NAEVR: Disappointed in President Obama's Proposed FY2013 Flat-Funding for NIH, Reduced NEI Funding

President Issues FY2013 Budget That Flat Funds NIH, Reduces NEI Funding

AEVR Announces Two Congressional Briefings to be Held in March 2012 on Key Vision Research Topics: Glaucoma and Deployment-Related Vision Trauma

NIH Issues Guidance on Salary Cap Reduction, Inflationary Increases

President Obama Signs FY2012 Appropriations Bill that Includes At Least $5 Million More for Vision Research

NIH Establishes NCATS, per the FY2012 Appropriations Conference Agreement

Congress Finalizes FY2012 Appropriations With an NIH/NEI Increase Although A Continuing Resolution Funds the Government through December 23

Congress Finalizes FY2012 Appropriations with a Decrease in Peer Reviewed Medical Research-Vision Funding

NAEVR Releases Fall 2011 Contributor Report

Congress Passes Third FY2012 Continuing Resolution; Funds Government Through December 16

NIH’s SMRB Meets to Review Status of Recommendations

TATRC Begins Review of FY2011 Pre-Proposal Submissions

Media Highlights Proposed Defense Vision Cuts

House Passes Short-Term CR to Fund Government; Measure Goes to the White House

* * *

Click here to see older Breaking News Items


	The U.S. Congress should adequately fund eye and vision research at the NEI. Eye and vision disease is now at epidemic proportions. As of the year 2000 census, more than 119 million Americans age 40+ were at risk from age-related eye disease, such as age-related macular degeneration, diabetic retinopathy, glaucoma and cataracts. More than 35 million Americans age 40+ currently experience these diseases, in addition to the 3.4 million who are blind, and this number is expected to grow to 50 million by the year 2020. A growing Hispanic and African American population is experiencing a disproportionate incidence of glaucoma and cataracts. And, the epidemic of diabetes is increasing the onset of diabetic retinopathy, the leading cause of blindness in individuals 25-74 years in age.

AEVR's Decade of Vision 2010-2020

AEVR Supports VA
Research Week

NAEVR Testifies at House Hearing and Requests FY2013 NEI Funding of $730 Million

Vision Enhancement System Addresses Defense Vision Research Gaps

AEVR Releases Updated Silver Book®:Vision Loss at 2012 World Glaucoma Week Congressional Briefing

NAEVR Meets with White House on Defense Vision Research Funding

NIH Director Dr. Collins Applauds NAEVR’s Efforts

NAEVR Meets with FDA To Discuss Change in Ophthalmic Drug Reviewing Division

NEI Clinician Scientist Discusses Lifestyle and AMD

Capitol Hill Education Focuses on Diabetic Retinopathy

NAEVR’s James Jorkasky Speaks on Vision Research Funding Advocacy at the European Union in Brussels

Congressional Briefing Highlights NIH’s Drug Discovery Technology

International Innovation Features Interview with NAEVR’s James Jorkasky

* * *

Click here to see older NAEVR in Action Items


	The NEI estimates that, currently, more than 38 million Americans age 40 and older experience blindness, low vision or an age-related eye disease such as AMD, glaucoma, diabetic retinopathy, or cataracts. This is expected to grow to more than 50 million Americans by year 2020.

Site Designed by: